Sogi, K. M., Lien, K. A., Johnson, J. R., Krogan, N. J., & Stanley, S. A. (2017). The Tyrosine Kinase Inhibitor Gefitinib Restricts Mycobacterium tuberculosis Growth through Increased Lysosomal Biogenesis and Modulation of Cytokine Signaling. ACS Infect Dis.

Sogi, Kimberly M., Katie A. Lien, Jeffrey R. Johnson, Nevan J. Krogan, and Sarah A. Stanley. "The Tyrosine Kinase Inhibitor Gefitinib Restricts Mycobacterium Tuberculosis Growth Through Increased Lysosomal Biogenesis and Modulation of Cytokine Signaling." ACS Infect Dis 2017.

Sogi, Kimberly M., et al. "The Tyrosine Kinase Inhibitor Gefitinib Restricts Mycobacterium Tuberculosis Growth Through Increased Lysosomal Biogenesis and Modulation of Cytokine Signaling." ACS Infect Dis 2017.